Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2
Sharad K. Verma(GlaxoSmithKline (United States)), William H. Miller(Clinical Innovations (United States)), Alan P. Graves(GlaxoSmithKline (United States)), Michael T. McCabe(GlaxoSmithKline (United States)), Art Shu(GlaxoSmithKline (United States)), Louis V. LaFrance(Johnson & Johnson (United States)), Steven D. Knight(GlaxoSmithKline (United States)), Xinrong Tian(GlaxoSmithKline (United Kingdom)), James Brackley(GlaxoSmithKline (United States)), Stuart P. Romeril(GlaxoSmithKline (United States)), Céline Duquenne(GlaxoSmithKline (United Kingdom)), Peter J. Tummino(Intarcia Therapeutics (United States)), Elsie Diaz(Johnson & Johnson (United States)), Heidi M. Ott(GlaxoSmithKline (United Kingdom)), D. Scherzer(GlaxoSmithKline (United States)), Glenn S. Van Aller(GlaxoSmithKline (United Kingdom)), Ryan G. Kruger(Arysta LifeScience (France)), Neil W. Johnson(Brandywine Photonics (United States)), Joelle L. Burgess(GlaxoSmithKline (United States)), Caretha L. Creasy, Seth W. Grant(GlaxoSmithKline (United States)), Yong Jiang(GlaxoSmithKline (United States)), Carl A. Machutta(South College), Kenneth A. Newlander(GlaxoSmithKline (United States)), Dominic Suarez(GlaxoSmithKline (United States)), Christine Thompson(GlaxoSmithKline (United Kingdom)), Dashyant Dhanak(Wilmington University)
Cited by 377
Related Papers
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848